Effect of nonenzymatic glycation of albumin and superoxide dismutase by glucuronic acid and suprofen acyl glucuronide on their functions in vitro

Chemico-Biological Interactions

Volumn 121, Issue 2, 1999, Pages 141-159

  Chiou, Yi Jin ^a   Tomer, Kenneth B ^b   C Smith, Philip ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Acyl glucuronides; Albumin; Covalent binding; Glycation; Protein; Superoxide dismutase

Indexed keywords

ALBUMIN; DIAZEPAM; GLUCOSE; GLUCURONIC ACID; GLUCURONIDE; SUPEROXIDE DISMUTASE; SUPROFEN; WARFARIN;

ADSORPTION; ARTICLE; CONTROLLED STUDY; COVALENT BOND; DRUG GLUCURONIDATION; DRUG PROTEIN BINDING; ENZYME ACTIVITY; GLYCATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN BINDING; PROTEIN GLYCOSYLATION;

ANIMALS; BINDING, COMPETITIVE; CATTLE; CHROMATOGRAPHY, AFFINITY; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIAZEPAM; GLUCOSE; GLUCURONATES; GLUCURONIC ACID; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; SERUM ALBUMIN; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; SUPEROXIDE DISMUTASE; SUPROFEN; WARFARIN;

EID: 0032996536     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(99)00098-8     Document Type: Article

References (45)

1. Brownlee M., Vlassara H., Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann. Intern. Med. 101:1984;527-537.
2. Emekli N. Nonenzymatic glycosylation of tissue and blood proteins. J. Marmara. Univ. Dental Faculty. 2:1996;530-534.
3. Cerami A. Accumulation of advanced glucosylation end products on proteins and nucleic acids: Role in aging. Eaton J.W., Konzen D.K., White J.G. Cellular and Molecular Aspects of Aging: The Red Cell as a Model. 1985;79-88 Alan R. Liss, New York.
4. McPherson J.D., Shilton B.H., Walton D.J. Role of fructose in glycation and cross-linking of proteins. Biochemistry. 27:1988;1901-1907.
5. Suarez G., Rajaram R., Oronsky A.L., Gwinowicz M.A. Nonenzymatic glycation of bovine serum albumin by fructose (fructation): comparison with the Maillard reaction initiated by glucose. J. Biol. Chem. 264:1989;3674-3679.
6. Beswick H.T., Harding J.J. Conformational changes induced in lens α- and γ-crystallins by modification with glucose-6-phosphate. Biochem. J. 246:1987;761-769.
7. Zaman Z., Verwilghen P.J. Non-enzymatic glycosylation of horse spleen and rat liver ferritins. Biochim. Biophys. Acta. 669:1981;120-124.
8. Dutton G.J. Glucuronidation of Drugs and Other Compounds. 1980;CRC Press, Boca Raton, FL.
9. Smith P.C., Wang C. Nonenzymic glycation of albumin by acyl glucuronide in vitro: comparison of reactions with reducing sugars. Biochem. Pharmacol. 44:1992;1661-1668.
10. Smith P.C., Langendijk P.N.J., Bosso J.A., Benet L.Z. Effect of probencid on the formation and elimination of acyl glucuronides: studies with zomepirac. Clin. Pharmacol. Ther. 38:1985;121-127.
11. McKinnon G.E., Dickinson R.G. Covalent binding of diflunisal and probenecid to plasma protein in humans: persistence of the adducts in the circulation. Res. Commun. Chem. Pathol. Pharmacol. 66:1989;339-354.
12. Hasegawa J., Smith P.C., Benet L.Z. Apparent intramolecular acyl migration of zomepirac glucuronide. Drug. Metab. Dispos. 10:1982;469-473.
13. Meffin P.J., Zilm D.M., Veenendaal J.R. Reduced clofibric acid clearance in renal dysfunction is due to a futile cycle. J. Pharmacol. Exp. Ther. 227:1983;732-738.
14. Hyneck M.L., Munafo A., Benet L.Z. Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide. Drug. Metab. Dispos. 16:1988;322-324.
15. Smith P.C., Benet L.Z., McDonagh A. Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism. Drug. Metab. Dispos. 18:1990;639-644.
16. Sallustio B.C., Fairchild B.A., Pannall P.R. Interaction of human serum albumin with the electrophilic metabolite 1-O-gemfibrozil-β-D-glucoronide. Drug. Metab. Disopos. 25:1997;55-60.
17. Stogniew M., Fenselau C. Electrophilic reactions of acyl-linked glucuronides-formation of clofibrate mercapturate in human. Drug. Metab. Dispos. 10:1982;609-613.
18. Hasegawa J., Smith P.C., Benet L.Z. Apparent intramolecular acyl migration of zomepirac glucuronide. Drug. Metab. Dispos. 10:1982;469-473.
19. Liu J.G., Malone R.S., Stallings H., Smith P.C. Influence of renal failure in rats on the disposition of salicyl acyl glucuronide and covalent binding of salicylate to plasma proteins. J. Pharmacol. Exp. Ther. 278:1996;277-283.
20. Monnier V.M., Cerami A. Nonenzymatic glycosylation and browning of proteins in vivo. Waller G.R., Feather M.S. The Maillard Reaction in Foods and Nutrition, American Chemical Society Symposium Series No. 215. 1983;431-439 The American Chemical Society, Washington, DC.
21. Shaklai N., Garlick R.L., Bunn H.R. Nonenzymatic glycosylation of human serum albumin alters its conformation and function. J. Biol. Chem. 259:1984;3812-3817.
22. Witztum J.L., Steinbrecher U.P., Fisher M., Kesaniemi A. Nonenzymatic glucosylation of homologous low density lipoprotein and albumin renders them immunogenic in the guinea pig. Proc. Natl. Acad. Sci. USA. 80:1983;2757-2761.
23. Paul R.G., Bailey A.J. Glycation of collagen: the basis of its central role in the late complications of ageing and diabetes. Intern. J. Biochem. Cell. Biol. 28:1996;1297-1310.
24. Vlassara H. Protein glycation in the kidney: role in diabetes and aging. Kidney Intern. 49:1996;1795-1804.
25. Mereish H., Roesnberg H., Cobby J. Glucosylated albumin and its influence on salicylate binding. J. Pharm. Sci. 71:1982;235-238.
26. Igaki A., Kobayashi K., Kimura M., Sakoguchi T., Matsyoka A. Influence of blood proteins on biomedical analysis. XII. Effects of glycation on gliclazide (oral hypoglycemic drug)-binding with serum albumin in diabetics. Chem. Pharm. Bull. 40:1992;255-257.
27. Sakurai T., Matsuyama M., Tsuchiya S. Glycation of erythrocyte superoxide dismutase reduces its activity. Chem. Pharm. Bull. 35:1987;302-307.
28. Kawamura N., Ookawara T., Suzuki K., Konishi K., Mino M., Taniguchi N. Increased glycated Cu, Zn-superoxide dismutase levels in erythrocytes of patients with insulin-dependent diabetes mellitus. J. Clin. Endocrinol. Metab. 74:1992;1352-1354.
29. Spahn-Langguth H., Benet L.Z. Acyl glucuronides revisited: is the glucuronidation process a toxification as well as a detoxification mechanism? Drug. Metab. Rev. 24:1992;5-48.
30. Bakke O.M., Wardell W.M., Lasagna L. Drug discontinuations in the United Kingdom and the United States, 1964 to 1983: issues of safety. Clin. Pharmacol. Ther. 35:1984;559-567.
31. Bakke O.M., Manocchia M., de Abajo F., Kaitin K.I., Lasagna L. Drug safety discontinuations in the United Kingdom, the United States, and Spain from 1974 through 1993: a regulatory perspective. Clin. Pharmacol. Ther. 58:1995;108-117.
32. Zittle C. Reaction of borate with substances of biological interest. Adv. Enzymol. 12:1951;493-527.
33. Brad M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
34. Smith P.C., Liu J.H. Covalent binding of suprofen acyl glucuronide to albumin in vitro. Xenobiotica. 23:1993;337-348.
35. McCord J.M., Fridovich I. Superoxide dismutase: an enzymic function for erythrocuprein (hemocuprein). J. Biol. Chem. 244:1969;6049-6055.
36. Lapolla A., Gerhardinger C., Baldo L., Fedele D., Keane A., Seraglia R., Catinella S., Traldi P. A study on in vitro glycation processes by matrix-assisted laser desorption ionization mass spectrometry. Biochim. Biophys. Acta. 1255:1993;33-38.
37. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol. Rev. 33:1981;17-53.
38. Iwakawa S., Spahn H., Benet L.Z., Lin E.T. Stereoselective binding of the glucuronide conjugates of carprofen enantiomers to human serum albumin. Biochem. Pharmacol. 39:1990;949-953.
39. Wanwimolruk S., Birkett D.J., Brooks P.M. Protein binding of some non-steroidal anti-inflammatory drugs in rheumatoid arthritis. Clin. Pharmacokinet. 7:1982;85-92.
40. Wanwimolruk S., Birkett D.J., Brooks P.M. Structural requirements for drug binding to site II on human serum albumin. Mol. Pharmacol. 24:1983;458-463.
41. Maruyama C., Lin C., Yamasaki K., Miyoshi T., Imai T., Yamasaki M., Otagiri M. Binding of suprofen to human serum albumin: role of the suprofen carboxyl group. Biochem. Pharmacol. 45:1993;1017-1026.
42. Sallustio B.C., Knights K.M., Roberts B.J., Zacest R. In vivo covalent binding of clofibric acid to human plasma proteins and rat liver proteins. Biochem. Pharmacol. 42:1991;1421-1425.
43. Dubois N., Lapicque F., Maurice M., Pritchard M., Fournel-Gigleux S., Magdalou J., Abiteboul M., Siest G., Netter P. In vitro irreversible binding of ketoprofen glucuronide to plasma proteins. Drug. Metab. Dispos. 21:1993;617-623.
44. Hargus S.J., Martin B.M., George J.W., Pohl L.R. Covalent modification of rat liver dipeptidyl peptidase IV (CD26) by the nonsteroidal anti-inflammatory drug diclofenac. Chem. Res. Toxicol. 8:1995;993-996.
45. Bailey M.J., Worrall S., de Jersey J., Dickinson R.G. Zomepirac acyl glucuronide covalently modifies tubulin in vitro and in vivo and inhibits its assembly in an in vitro system. Chemico-Biological Interaction. 115:1998;153-166.